Persistent COVID-19 symptoms in a community study of 606,434 people in England

Matthew Whitaker, Joshua Elliott, Marc Chadeau‐Hyam, +5

Nature Communications

SARS-CoV-2 antibody prevalence in England following the first peak of the pandemic

Helen Ward, Christina Atchison, Matthew Whitaker, +10

Nature Communications

Antibody prevalence for SARS-CoV-2 following the peak of the pandemic in England: REACT2 study in 100,000 adults

Helen Ward, Christina Atchison, Matthew Whitaker, +10

Infectious Disease EpidemiologyAbstract Background EnglandAge-specific IfrVirus EpidemiologyEmerging Infectious Diseases +12

Population antibody responses following COVID-19 vaccination in 212,102 individuals

Helen Ward, Matthew Whitaker, Barnaby Flower, +10

Nature Communications

Antibody prevalence for SARS-CoV-2 in England following first peak of the pandemic: REACT2 study in 100,000 adults

Helen Ward, Christina Atchison, Matthew Whitaker, +11

medRxiv

Virus EpidemiologyReact2 StudyCovid-19 PandemicLarge OutbreakVirology +11

Declining prevalence of antibody positivity to SARS-CoV-2: a community study of 365,000 adults

Helen Ward, Graham Cooke, Christina Atchison, +12

ImmunohematologyVirus EpidemiologyImmunodeficienciesImmunologyImmunodominance +17

Rapid increase in Omicron infections in England during December 2021: REACT-1 study

Paul Elliott, Barbara Bodinier, Oliver Eales, +18

Science

React-1 StudyOmicron VariantDisease OutbreakSwab PositivityFlu Vaccination +26

Risk factors for positive and negative COVID-19 tests: a cautious and in-depth analysis of UK biobank data

Marc Chadeau‐Hyam, Barbara Bodinier, Joshua Elliott, +6

International Journal of Epidemiology

Variant-specific symptoms of COVID-19 in a study of 1,542,510 adults in England

Matthew Whitaker, Joshua Elliott, Barbara Bodinier, +5

Nature Communications

COVID-19 mortality in the UK Biobank cohort: revisiting and evaluating risk factors

Joshua Elliott, Barbara Bodinier, Matthew Whitaker, +5

European Journal of Epidemiology